scorecardresearch
Sunday, July 20, 2025
TopicPharmaceutical

Topic: pharmaceutical

Here’s why Nepal banned 16 Indian pharma companies, including Patanjali’s Divya Pharmaceuticals

Nepal had sent a team to India in April and July to inspect the manufacturing facilities of pharmaceutical firms that had applied to supply their products to the neighbouring country.

Cough syrups made by Delhi-based Maiden Pharma may be tied to 66 deaths in Gambia, says WHO

In July, alarm was raised in Gambia after several children began falling ill with kidney problems. WHO has issued an alert asking regulators to remove the company's goods from the market.

CBI chargesheet in Biocon case raises questions about how India manages drug trials

CBI action against CDSCO official accused of corruption draws attention to India’s drug regulatory framework & changes brought to expedite access to latest drugs & pharmaceutical products.

Bajaj Healthcare is first private entity to enter highly-regulated opium processing sector 

Although India is one of the few countries that permit opium cultivation, its processing has so far been highly centralised.

India banks on Hyderabad’s ‘Pharma City’ to break China’s stranglehold over drug supplies

India’s $42 billion drug manufacturing industry relies intensely on China, which supplies almost 70% of the active pharmaceutical ingredients that go into making medicines.

Western companies should supply essential medicines to Ukraine, not pull out entirely

Putin may not be swayed by the suffering of people. Any interruption of supply of medicines can create human misery without any gain.

Pandemic can’t be allowed to devastate nations because of sophisticated, one-sided WTO rules

For President Joe Biden to take a stand against pharmaceutical companies is no small matter. His presidential campaign was the near sole beneficiary of pharma largesse in 2020.

Antidepressant Escitalopram ‘linked to suicidal thoughts’, must carry strongest warning — govt

Citing FDA warning, India's drug regulator starts examining warnings, prescribing information and package inserts given by Indian drugmakers manufacturing Escitalopram.

J&J’s new flu drug flop shows how difficult it is to fight viruses

Johnson & Johnson stopped developing the drug pimodivir in the final stage of testing it for patients with influenza A, the most common cause of flu, after a study indicated it won't work.

How a Chinese firm jumped to the front of the global Covid vaccine race

China’s pharma industry has been dogged by safety incidents & quality scandals. But in recent years, hundreds of Chinese scientists trained in the West have come home.

On Camera

Can Syria’s tiny Druze minority survive West Asia’s new storms? There’s little hope

Indians see West Asia as one uninterrupted wash of Islam, but the reality is more complex. For the Druze, support from Israel—where they are a recognised minority—is now critical.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.